161 related articles for article (PubMed ID: 37904542)
1. Valganciclovir modulates the tumor necrosis factor axis molecules expression and CD4+ T-cell subsets in disseminated Kaposi Sarcoma patients.
Ramon-Luing LA; Flores-Gonzalez J; Angel García-Rojas L; Islas-Muñoz B; Volkow-Fernández P; Chavez-Galan L
Clin Exp Immunol; 2024 Feb; 215(2):190-201. PubMed ID: 37904542
[TBL] [Abstract][Full Text] [Related]
2. Valganciclovir as Add-On Therapy Modifies the Frequency of NK and NKT Cell Subpopulations in Disseminated Kaposi Sarcoma Patients.
Flores-Gonzalez J; Ramon-Luing LA; Ocaña-Guzman R; Buendia-Roldan I; Islas-Muñoz B; Volkow-Fernández P; Chavez-Galan L
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053573
[TBL] [Abstract][Full Text] [Related]
3. Impact of valganciclovir therapy on severe IRIS-Kaposi Sarcoma mortality: An open-label, parallel, randomized controlled trial.
Volkow P; Chavez Galan L; Ramon-Luing L; Cruz-Velazquez J; Cornejo-Juarez P; Sada-Ovalle I; Perez-Padilla R; Islas-Muñoz B;
PLoS One; 2023; 18(5):e0280209. PubMed ID: 37195970
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of membrane-bound tumor necrosis factor-alpha and tumor necrosis factor receptors on mononuclear cells in human immunodeficiency virus type 1 infection: low percentage of p75-tumor necrosis factor receptor positive cells in patients with advanced disease and high viral load.
Hestdal K; Aukrust P; Müller F; Lien E; Bjerkeli V; Espevik T; Frøland SS
Blood; 1997 Oct; 90(7):2670-9. PubMed ID: 9326234
[TBL] [Abstract][Full Text] [Related]
5. Immunophenotypic analysis in participants with Kaposi sarcoma following pomalidomide administration.
Lurain K; Polizzotto MN; Krug LT; Shoemaker G; Singh A; Jensen SMR; Wyvill KM; Ramaswami R; Uldrick TS; Yarchoan R; Sereti I
AIDS; 2023 Sep; 37(11):1693-1703. PubMed ID: 37352498
[TBL] [Abstract][Full Text] [Related]
6. Differential effect of human herpesvirus 6A on cell division and apoptosis among naive and central and effector memory CD4+ and CD8+ T-cell subsets.
Gupta S; Agrawal S; Gollapudi S
J Virol; 2009 Jun; 83(11):5442-50. PubMed ID: 19297473
[TBL] [Abstract][Full Text] [Related]
7. Kaposi sarcoma in people living with HIV: incidence and associated factors in a French cohort between 2010 and 2015.
Poizot-Martin I; Lions C; Cheret A; Rey D; Duvivier C; Jacomet C; Allavena C; Huleux T; Bani-Sadr F; Obry-Roguet V; Makinson A;
AIDS; 2020 Mar; 34(4):569-577. PubMed ID: 31764070
[TBL] [Abstract][Full Text] [Related]
8. A Randomized Placebo-Controlled Efficacy Study of a Prime Boost Therapeutic Vaccination Strategy in HIV-1-Infected Individuals: VRI02 ANRS 149 LIGHT Phase II Trial.
Lévy Y; Lacabaratz C; Lhomme E; Wiedemann A; Bauduin C; Fenwick C; Foucat E; Surenaud M; Guillaumat L; Boilet V; Rieux V; Bouchaud O; Girard PM; Molina JM; Morlat P; Hocqueloux L; Richert L; Pantaleo G; Lelièvre JD; Thiébaut R
J Virol; 2021 Apr; 95(9):. PubMed ID: 33568510
[TBL] [Abstract][Full Text] [Related]
9. GB virus C infection is associated with altered lymphocyte subset distribution and reduced T cell activation and proliferation in HIV-infected individuals.
Stapleton JT; Chaloner K; Martenson JA; Zhang J; Klinzman D; Xiang J; Sauter W; Desai SN; Landay A
PLoS One; 2012; 7(11):e50563. PubMed ID: 23209780
[TBL] [Abstract][Full Text] [Related]
10. [Abnormal Activation of T Cells in HIV-1 Infection After Antiretroviral Therapy].
Guo Y; Zhang YL; Zhu D; Gong FH; Gao YS; Zhu KR; Li SS
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 54(2):415-421. PubMed ID: 36949708
[TBL] [Abstract][Full Text] [Related]
11. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
[TBL] [Abstract][Full Text] [Related]
12. Compartmentalized T cell profile in the lungs of patients with HIV-1-associated pulmonary Kaposi sarcoma.
Matiza T; Boyd KF; Lyall RA; Kwon DS; McGregor AM; Fiorillo S; Campbell TB; Borok M; Corleis B
Medicine (Baltimore); 2021 Dec; 100(51):e28328. PubMed ID: 34941134
[TBL] [Abstract][Full Text] [Related]
13. Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapy.
Benito JM; López M; Lozano S; Ballesteros C; Martinez P; González-Lahoz J; Soriano V
J Acquir Immune Defic Syndr; 2005 Apr; 38(4):373-81. PubMed ID: 15764953
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of plasma human herpesvirus 8 DNA as a marker of clinical outcomes during antiretroviral therapy for AIDS-related Kaposi sarcoma in Zimbabwe.
Borok M; Fiorillo S; Gudza I; Putnam B; Ndemera B; White IE; Gwanzura L; Schooley RT; Campbell TB
Clin Infect Dis; 2010 Aug; 51(3):342-9. PubMed ID: 20572760
[TBL] [Abstract][Full Text] [Related]
15. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience.
Gray CM; Schapiro JM; Winters MA; Merigan TC
AIDS Res Hum Retroviruses; 1998 May; 14(7):561-9. PubMed ID: 9591710
[TBL] [Abstract][Full Text] [Related]
16. Treatment interruption in chronically HIV-infected patients with an ultralow HIV reservoir.
Calin R; Hamimi C; Lambert-Niclot S; Carcelain G; Bellet J; Assoumou L; Tubiana R; Calvez V; Dudoit Y; Costagliola D; Autran B; Katlama C;
AIDS; 2016 Mar; 30(5):761-9. PubMed ID: 26730568
[TBL] [Abstract][Full Text] [Related]
17. Association of CD8+ T lymphocyte subsets with the most commonly used markers to monitor HIV type 1 infection in children treated with highly active antiretroviral therapy.
Navarro J; Resino S; Bellón JM; Abad ML; Gurbindo D; Fernández-Cruz E; Muñóz-Fernández MA
AIDS Res Hum Retroviruses; 2001 Apr; 17(6):525-32. PubMed ID: 11350666
[TBL] [Abstract][Full Text] [Related]
18. A novel mathematical model of AIDS-associated Kaposi's sarcoma: Analysis and optimal control.
Kaondera-Shava RF; Lungu E; Szomolay B
Biosystems; 2021 Feb; 200():104318. PubMed ID: 33309554
[TBL] [Abstract][Full Text] [Related]
19. CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies.
Caby F; Guiguet M; Weiss L; Winston A; Miro JM; Konopnicki D; Le Moing V; Bonnet F; Reiss P; Mussini C; Poizot-Martin I; Taylor N; Skoutelis A; Meyer L; Goujard C; Bartmeyer B; Boesecke C; Antinori A; Quiros-Roldan E; Wittkop L; Frederiksen C; Castagna A; Thurnheer MC; Svedhem V; Jose S; Costagliola D; Mary-Krause M; Grabar S;
Clin Infect Dis; 2021 Jul; 73(1):50-59. PubMed ID: 34370842
[TBL] [Abstract][Full Text] [Related]
20. Regulatory T Cell Effect on CD8
Lepone LM; Rappocciolo G; Piazza PA; Campbell DM; Jenkins FJ; Rinaldo CR
AIDS Res Hum Retroviruses; 2017 Jul; 33(7):668-674. PubMed ID: 28121161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
